PRRT

You have access
¹⁷⁷Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I Trial
Andreas Hallqvist, Elva Brynjarsdóttir, Tomas Krantz, Marie Sjögren, Johanna Svensson and Peter Bernhardt

Journal of Nuclear Medicine May 1, 2025, 66 (5) 707-712; DOI: https://doi.org/10.2967/jnumed.124.268902
Open Access
Side-by-Side Comparison of the In Vivo Performance of [²¹²Pb]Pb-DOTAMTATE and Other SSTR2-Targeting Compounds
Amal Saidi, Tania A. Stallons, Amy G. Wong, Aaron T. Schatzmann, Ugur Soysal and Julien J. Torgue

Journal of Nuclear Medicine March 1, 2025, 66 (3) 391-397; DOI: https://doi.org/10.2967/jnumed.124.268345
You have access
Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
Adriana Amerein, Christoph Maurer, Malte Kircher, Alexander Gäble, Anne Krebold, Andreas Rinscheid, Oliver Viering, Christian H. Pfob, Ralph A. Bundschuh, Lars Behrens, Arthur JAT Braat, Ansgar Berlis and Constantin Lapa

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1911-1916; DOI: https://doi.org/10.2967/jnumed.124.268217
You have access
Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy
Lisa Steinhelfer, Friederike Jungmann, Lukas Endrös, Patrick Wenzel, Bernhard Haller, Manuel Nickel, Eva Haneder, Fabian Geisler, Katharina Götze, Alexander von Werder, Matthias Eiber, Markus R. Makowski, Rickmer Braren and Fabian Lohöfer

Journal of Nuclear Medicine August 1, 2024, 65 (8) 1244-1249; DOI: https://doi.org/10.2967/jnumed.123.267098
You have access
Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
Alexandros Moraitis, Walter Jentzen, Pedro Fragoso Costa, David Kersting, Stephan Himmen, Marta Coelho, Marian Meckel, Cees J.A. van Echteld, Wolfgang P. Fendler, Ken Herrmann and Miriam Sraieb

Journal of Nuclear Medicine June 1, 2024, 65 (6) 931-937; DOI: https://doi.org/10.2967/jnumed.123.266619
You have access
Efficacy of [⁶⁷Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2–Positive Neuroendocrine Tumors
Fabrice Ngoh Njotu, Jessica Pougoue Ketchemen, Anjong Florence Tikum, Hanan Babeker, Brian D. Gray, Koon Y. Pak, Maruti Uppalapati and Humphrey Fonge

Journal of Nuclear Medicine April 1, 2024, 65 (4) 533-539; DOI: https://doi.org/10.2967/jnumed.123.265997
You have access
Sequencing of Somatostatin-Receptor–Based Therapies in Neuroendocrine Tumor Patients
Jonathan R. Strosberg, Taymeyah Al-Toubah, Ghassan El-Haddad, Diane Reidy Lagunes and Lisa Bodei

Journal of Nuclear Medicine March 1, 2024, 65 (3) 340-348; DOI: https://doi.org/10.2967/jnumed.123.265706
You have access
Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
Liene Friebe, Martin T. Freitag, Martin Braun, Guillaume Nicolas, Andreas Bauman, David Bushnell, Emanuel Christ and Damian Wild

Journal of Nuclear Medicine February 1, 2024, 65 (2) 228-235; DOI: https://doi.org/10.2967/jnumed.123.265894
You have access
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network
Laure Al Mansour, Louis De Mestier, Magalie Haissaguerre, Pauline Afchain, Julien Hadoux, Thierry Lecomte, David Morland, Anne Segolene Cottereau, Ophelie De Rycke, Ghoufrane Tlili, Jérémie Tordo, Marc Janier, Agathe Deville and Thomas Walter

Journal of Nuclear Medicine February 1, 2024, 65 (2) 258-263; DOI: https://doi.org/10.2967/jnumed.123.266063
You have access
Impact of Single-Time-Point Estimates of ¹⁷⁷Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles
Alexandre Chicheportiche, Moshe Sason, Mahmoud Zidan, Jeremy Godefroy, Yodphat Krausz, David J. Gross, Simona Grozinsky-Glasberg and Simona Ben-Haim

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1610-1616; DOI: https://doi.org/10.2967/jnumed.122.264923

Main menu

User menu

Search

PRRT

Pages